As governments gathered for the UN CBD Working Group meeting in Granada in Jan 2006, indigenous peoples, farmers’ groups and NGOs renewed their calls for an international ban on ‘Terminator Technology’. […]
|
||||||
|
As governments gathered for the UN CBD Working Group meeting in Granada in Jan 2006, indigenous peoples, farmers’ groups and NGOs renewed their calls for an international ban on ‘Terminator Technology’. […] The latest round of UN talks held in Granada, Jan 2006 on an international agreement on access and benefit-sharing reflected the all-too-familiar tensions and conflicts between the developed and developing countries. […] A UN meeting held in Jan 2006 was an opportune occasion to revisit the difficult issues that states, indigenuous and local communities need to grapple with as they come to grips with the interplay of biodiversity and IPRs. […] This is a report on the health situation of Bt cotton growing farmers in Madhya Pradesh, India following complaints of allergenic reactions among farmers growing GM cotton. […] This is an analysis on key decisions taken at the 3rd meeting of the Parties of the Cartagena Protocol on Biosafety which met from 13-17 March in Curitiba, Brazil. […] At the 3rd meeting of the Parties of the Cartagena Protocol on Biosafety in Brazil, agreement was finally reached on international documentation requirements for bulk shipments of genetically modified commodity grains. […] This is a peer-reviewed paper based on the report ‘Genome Scrambling-Myth or Reality?’ by Jonathan R. Latham, Allison K.Wilson, and Ricarda A. Steinbrecher. […] This report is the first from the on-line GM Contamination Register and reviews cases reported of contamination, illegal plantings and releases of GM organisms, and negative agricultural side-effects of GMOs. […] A website that publishes videos and information about the negotiations and side events at the 3rd Meeting of Parties of the Cartagena Protocol on Biosafety in Brazil. […] This is an assessment of the interim report of the WTO Panel considering the case “European Communities – Measures Affecting the Approval and Marketing of Biotech Products” which was made available to the parties in the dispute. […] |
||||||
|
All our content may be republished or reused for free, except where otherwise noted. This site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Powered by WordPress & Atahualpa |
||||||